Literature DB >> 23042547

HBV promotes the proliferation of hepatic stellate cells via the PDGF-B/PDGFR-β signaling pathway in vitro.

Qixuan Bai1, Jing An, Xiaoning Wu, Hong You, Hong Ma, Tianhui Liu, Na Gao, Jidong Jia.   

Abstract

The activation of hepatic stellate cells (HSCs) is closely associated with liver fibrosis in chronic hepatitis B virus (HBV) infection. However, the molecular mechanisms leading to HSC activation remain unclear. It has been reported that the platelet-derived growth factor-B (PDGF-B)/PDGF receptor-β (PDGFR-β) signaling pathway is involved in this process. Thus, we investigated whether HBV and its protein contribute to HSC proliferation by the PDGF-B/PDGFR-β signaling pathway. HBV particles were purified from the supernatant of HepG2.2.15 cells by ultracentrifugation and the cell lines carrying HBV preS, e, c or x genes were obtained. After incubation with HBV particles or co-cultured with the cell lines expressed in the viral protein, the proliferation of LX-2 cells, an HSC cell line, were detected by flow cyto-metry and real-time PCR and the expression of molecules related to the PDGF-B/PDGFR-β signaling pathway were further measured. Our results indicated that HBV particles, c and x proteins promoted LX-2 proliferation and increased the mRNA levels of PDGF-B, PDGFR-β, collagen-I and α-smooth muscle actin (α-SMA), as well as the phosphorylation of PDGFR-β; however, the expression protein levels of PDGF-B and PDGFR-β remained unchanged. In conclusion, HBV particles and HBV c and x proteins promote HSC proliferation and fibrogenesis in vitro and the PDGF-B/PDGFR-β signaling pathway is important in this process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23042547     DOI: 10.3892/ijmm.2012.1148

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  16 in total

1.  Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants.

Authors:  Caroline Lefeuvre; Marine Roux; Simon Blanchard; Hélène Le Guillou-Guillemette; Jérôme Boursier; Françoise Lunel-Fabiani; Pascale Jeannin; Adeline Pivert; Alexandra Ducancelle
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

Review 2.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

Review 3.  Hepatic stellate cells as key target in liver fibrosis.

Authors:  Takaaki Higashi; Scott L Friedman; Yujin Hoshida
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 17.873

4.  A novel non-invasive index using AFP and APTT is associated with liver fibrosis in patients with chronic hepatitis B infection: a retrospective cohort study.

Authors:  Limin Feng; Ke Sun; Jie Zhang; Guofang Feng; Ying Zhao
Journal:  BMJ Open       Date:  2015-09-21       Impact factor: 2.692

5.  Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx.

Authors:  Jin Gong; Wei Tu; Jian Han; Jiayi He; Jingmei Liu; Ping Han; Yunwu Wang; Mengke Li; Mei Liu; Jiazhi Liao; Dean Tian
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

6.  Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.

Authors:  Dexin Wang; Ping Zhang; Min Zhang
Journal:  Exp Ther Med       Date:  2017-09-29       Impact factor: 2.447

7.  Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.

Authors:  Yunching Chen; Yuhui Huang; Thomas Reiberger; Annique M Duyverman; Peigen Huang; Rekha Samuel; Lotte Hiddingh; Sylvie Roberge; Christina Koppel; Gregory Y Lauwers; Andrew X Zhu; Rakesh K Jain; Dan G Duda
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

8.  Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5.

Authors:  Chengcheng Zou; Yongguo Li; Yiyi Cao; Jinnan Zhang; Jingrong Jiang; Yanrui Sheng; Sen Wang; Ailong Huang; Hua Tang
Journal:  BMC Cancer       Date:  2014-02-17       Impact factor: 4.430

9.  Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells.

Authors:  Reina Sasaki; Tatsuo Kanda; Masato Nakamura; Shingo Nakamoto; Yuki Haga; Shuang Wu; Hiroshi Shirasawa; Osamu Yokosuka
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

Review 10.  Hepatitis B virus X protein in liver tumor microenvironment.

Authors:  Sha Fu; Rong-Rong Zhou; Ning Li; Yan Huang; Xue-Gong Fan
Journal:  Tumour Biol       Date:  2016-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.